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Abstract
Background: To report a case of disseminated fusariosis with endogenous endophthalmitis in a patient with acute
lymphoblastic leukemia. Transfusion-associated immune modulation secondary to platelet transfusion could play an
important role in the pathophysiology of this case.
Case Presentation: A 9 year-old male with acute lymphoblastic leukemia complicated by pancytopenia and
disseminated Intravascular coagulation was given platelet transfusion. He developed disseminated fusariosis and
was referred to the ophthalmology team for right endogenous endophthalmitis. The infection was controlled with
aggressive systemic and intravitreal antifungals.
Conclusion: Patients with acute lymphoblastic leukemia are predisposed to endogenous fungal endophthalmitis.
Transfusion-associated immune modulation may further increase host susceptibility to such opportunistic infections.
Background
Endogenous fungal endophthalmitis is a serious sight
threatening condition, occur mostly in immunocompro-
mised patients. Patients with acute lymphoblastic leukemia
require aggressive polychemotherapy with high risk of
bone marrow suppression. Frequent transfusion of blood
product may result in transfusion-associated immune
modulation (TRIM) which further increases host suscept-
ibility to opportunistic infection. TRIMs are mostly asso-
ciated with the transfusion of allogenic white blood cells.
We report a case of disseminated fusariosis and endogen-
ous fungal endophthalmitis in a patient with acute lym-
phoblastic leukemia (ALL) after platelet transfusion.
Case Presentation
A 9 year old male was diagnosed of precursor B-CALLA
positive ALL in December 2006, and was on
maintenance therapy since February 2007. He had testi-
cular relapse in June 2009 and central nervous system
(CNS) involvement in March 2010. He was treated
according to ALL R3 protocol phase III intensification
which consist intravenous vincristine 1.5 mg, intrave-
nous cytarabine 3,000 mg/m2 and intrathecal methotrex-
ate 12 mg.
In June 2010, he developed pancytopenia with low
grade fever (37-38 degree Celsius). Haemoglobin was 8.7
g/dL, red cell count 3.18 × 1012/L, white cell count 0.2
× 109/L and platelet count 19 × 109/L.
The Disseminated Intra-Vascular Coagulation (DIVC)
screening test was positive; Prothrombin time (PT) 16.9
seconds, International Normalized Ratio (INR) 1.42,
Activated Partial Thromboplastin Time (APTT) 67.8
seconds, APTT ratio 1.75, fibrinogen level 8.79 g/dL and
D-Dimer 2.67 ug/ml. The patient was given urgent
transfusion of irradiated apheresis platelet, fresh frozen
plasma and cryoprecipitate.
Within 48 hour of platelet transfusion, the patient
developed generalized tender, papular rash. The rash
was initially thought to be of viral origin. Skin biopsy
revealed dermis infiltration by septated, non-pigmented
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fungal hyphae (Figure 1). Fungal antigen tests for asper-
gillus and candida antigen were negative. Ultrasonogra-
phy of both legs showed disseminated fungal granuloma
(Figure 2). Computer Tomography (CT) abdomen
showed an abscess at the posterior cortex of the lower
pole of the left kidney (Figure 3). There were also multi-
ple subcutaneous abscesses (Figure 4). The patient was
treated with intravenous Amphotericin B Cholesterol
Dispersion (ABCD) 5 mg/kg 8 hourly. Blood culture was
positive for Fusarium species. Sensitivity to antifungals
was not performed due to technical difficulties. Subcuta-
neous granulocyte-colony stimulating factor (G-CSF)
125 mcg daily was given to counteract persistent neutro-
penia. After five days, the white cell count increased
from 0.4 × 109/L to 7.1 × 109/L, while the platelet count
was 110 × 109/L.
Three weeks after the onset of disseminated fungal
infection, the patient was still treated with intravenous
ABCD. He was referred to the ophthalmic team for red-
ness of left eye of two days duration. Visual acuity was
unable to be documented reliably. There was no relative
afferent pupillary defect (RAPD). Two septic iris nodules
appeared at the pupillary margin; intraocular pressure
(IOP) was 11 mm Hg. Red reflex was reduced due to
severe vitritis and numerous vitreous fungal balls. Optic
disc was hyperaemic with tortuosity of the retinal ves-
sels. The right eye was not involved. The diagnosis was
left endogenous fungal endophthalmitis, presumed to be
due to Fusarium species. He was treated with immediate
intravitreal voriconazole 100 mcg/0.1 ml, intravitreal
vancomycin 1 mg/0.1 ml and intravitreal ceftazidime 2.5
mg/0.1 ml. Vitreous and aqueous sample contained pus
cells without any identifiable microorganisms and cul-
ture was negative. Response to treatment was slow. Two
weeks after the first injection, a second intravitreal vori-
conazole 100 mcg/0.1 ml was given.
Two months after the second intravitreal voriconazole,
the visual acuity was 6/24 (decimal notation: 0.25) for
the left eye and 6/6 (decimal notation: 1.0) for the right
eye. There were numerous keratic precipitates and iris
pigments on the corneal endothelium (Figure 5). No
cells and flare in the anterior chamber. Vitreous opacity
and optic disc hyperaemia reduced, but with the devel-
opment of epiretinal membrane and subretinal fibrosis
(Figure 6). The white cell counts remain low at the vici-
nity of 2 - 4 × 109/L after resolution of the systemic
fungal infection.
Discussion
Children with acute lymphoblastic leukemia (ALL) who
relapse after successful frontline induction and consoli-
dation therapy can achieve long-term event-free survival
with aggressive polychemotherapy. A second remission
Figure 1 Histopathological specimen of the skin (PAS stain).
Figure 2 Ultrasonography of right leg. Hypoechoic lesion
(abscess) at subcutaneous tissue of posteromedial aspect of the
right leg.
Figure 3 CT abdomen (transverse view). Small hypodense lesion
(abscess) in the posterior cortex of the lower pole of the left kidney
(white arrow).
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is achieved by more intensive short-course elements
containing high-dose methotrexate and high-dose cytar-
abine [1]. For treatment or prevention of CNS leukemia,
intrathecal therapy is given during intensive treatment,
and CNS irradiation is administered after the end of
intensive chemotherapy [2]. In testicular relapse, local
irradiation or orchidectomy is performed [3]. Bone mar-
row suppression and pancytopenia is a known complica-
tion of both ALL itself and cancer chemotherapy.
Neutropenia increases patients’ susceptibility to oppor-
tunistic infections. To overcome neutropenia, subcuta-
neous injection of Granulocyte colony-stimulating factor
(G-CSF) is used to enhance the production of neutro-
phils within the bone marrow [4].
Blood transfusion is frequently needed for anemia and
thrombocytopenia. Urgent platelet transfusion is
required in this patient because of severe thrombocyto-
penia and DIVC.
Irradiated apheresis platelets were used. Irradiation
removes leukocytes from the platelet. The major advan-
tage of apheresis platelets is that enough platelets can be
collected from a single donor to constitute a transfusion
dose. The reduction in donor exposures by using apher-
esis platelets and the removal of leukocytes have the
advantages of reducing transfusion-transmitted infections
and the incidence of platelet alloimmunization.
The bacterial risk associated with platelet transfusions
is high because platelets are stored at 22°C rather than
at 4°C as are red cells [5]. However, the risk of contami-
nation of any blood product with fungal element is very
low. The development of fungal septicaemia within 48
hours of platelet transfusion in this patient could simply
due to superinfection in a case of immunosuppression
from ALL and immunosuppressive therapy. Alternatively
platelet transfusion may lead to TRIM which increases
the risk of endogenous fungal endophthalmitis above
and beyond that posed by leukemia.
TRIM occur as a result of allogeneic blood transfu-
sions (ABT) which induce clinically significant immuno-
suppression in recipients. Blood component transfusion
causes recipient immunomodulation, with stimulation of
certain immune responses and suppression of others,
resulting in an impaired immune competence. TRIM
has been linked to an improved clinical outcome in the
setting of renal allograft transplantation. Possible dele-
terious TRIM-associated effects include an increased
rate of cancer recurrence and of post-operative bacterial
infection. TRIM is attributed to immunomodulatory and
pro-inflammatory mechanisms. TRIM effects may be
mediated by allogeneic mononuclear cells, white-blood-
cell (WBC)-derived soluble mediators and soluble HLA
peptides circulating in allogeneic plasma [6].
The presence of platelet-derived bioactive substances
such as plasminogen activator inhibitor-1, tissue inhibi-
tor of metalloproteinases-1, vascular endothelial growth
factor and tissue factor, in platelet concentrates, may
play an important role in TRIM [7]. It is now known
that platelets possess cell membrane, cytoplasmic, and
Figure 4 CT abdomen (transverse view). Multiple small
subcutaneous abscesses(white arrows).
Figure 5 Anterior segment of the left eye.
Figure 6 Fundus photography of the left eye.
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secrete CD40 ligand (CD40L). Previously thought to be
involved only in hemostasis, platelets also function in
innate and adaptive immunity and possess proinflamma-
tory, as well as pro-thrombotic properties. They interact
with other platelets, endothelial cells, lymphocytes, den-
dritic cells, and fibroblasts. Soluble forms of CD40L
(sCD40L) in the human circulation are almost entirely
derived from platelets. Elevated levels of CD40L are
associated with vascular disease, abnormal clotting
(thrombosis), lung injury, and autoimmune disease [8].
All antifungals are fungistatic, therefore neutrophilic
recovery is important for the eradication of any dissemi-
nated fusariosis [9]. Early and aggressive local and sys-
temic antifungal therapy is crucial, although the visual
prognosis is generally poor. Binder et al identified visual
acuity at diagnosis and the presence of hypopyon as fac-
tors associated with outcome [10]. In their series, all
patients with visual acuity worse than 20/200 at diagno-
sis had final visual acuity of worse than 20/200. Two-
thirds of patients with hypopyon at diagnosis had final
visual outcomes worse than 20/200, whereas less than
one-third of patients without hypopyon at diagnosis had
final visual acuity worse than 20/200. There was no sig-
nificant difference in outcomes for patients undergoing
vitrectomy compared with those treated with intrave-
nous antibiotics or antifungal agents. Vitrectomy was
not performed for our patient due to unfavourable risk-
to-benefit ratio. The risk of amblyopia is minimal and
the patient was responding well to the combination of
intravitreal voriconazole and systemic amphotericin B.
Conclusion
This case report highlights the life-threatening and
sight-threatening complications of acute lymphoblastic
leukemia. TRIMs are mostly due to transfusion of allo-
genic white blood cells. However, other biological med-
iators of TRIM may exist. TRIMs are usually reported
in debilitated patients. The evidence of TRIM in this
case was masked by the presence of multiple confound-
ing factors (absence of evidence); but the absence of evi-
dence is not evidence of absence. As new evidence of
platelet’s capability to function in innate and adaptive
immunity is emerging, platelet transfusion may increases
the risk of endogenous fungal endophthalmitis above
and beyond that posed by leukemia. Although the link
between endogenous endophthalmitis and TRIM cannot
be established by a single case report, it is our hope that
this could path the way for future research in this area.
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